American College of Cardiology Foundation
Overview
The American College of Cardiology Foundation is a nonprofit medical association that makes strategic investments in health technology companies through its ACC Innovation Program.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Abridge Inc | Oct 2023 | Series B | Co-investor |
| Foodsmart | Jan 2024 | Series C Extension | Lead |
| Cleerly | Jun 2021 | Series B | Co-investor |
| cliexa | Feb 2025 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is American College of Cardiology Foundation based?
American College of Cardiology Foundation is headquartered in Washington D.C., United States.
When was American College of Cardiology Foundation founded?
American College of Cardiology Foundation was founded in 1949.
How many portfolio companies does American College of Cardiology Foundation have?
American College of Cardiology Foundation has 4 portfolio companies in Caplight's dataset.
What are some companies in American College of Cardiology Foundation's portfolio?
Portfolio companies visible on Caplight include Abridge Inc, Foodsmart, Cleerly, cliexa.
What was American College of Cardiology Foundation's most recent investment shown here?
American College of Cardiology Foundation's most recent investment in this portfolio sample was in cliexa in 2025.
What sectors does American College of Cardiology Foundation focus on?
American College of Cardiology Foundation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Consumer & Commerce.
What company stages does American College of Cardiology Foundation focus on?
American College of Cardiology Foundation typically invests at the Mid stage.
What is American College of Cardiology Foundation's AUM?
American College of Cardiology Foundation's assets under management are estimated between $100.0M and $250.0M.